Therapeutics and inflammatory bowel disease: a guide to the interpretation of randomized controlled trials.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 8536868.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Randomized controlled trials are the optimal means of assessing the efficacy of new treatments. This report reviews the methodology of clinical trials in inflammatory bowel disease using examples from recent randomized trials of therapy for Crohn's disease and other gastrointestinal diseases to show key principles. Guidelines for the practicing clinician to evaluate these studies are provided.
Medical subject headings
- Inflammatory Bowel Diseases
- Randomized Controlled Trials as Topic